About YouthBio Therapeutics

YouthBio Therapeutics develops partial cellular reprogramming gene therapies that restore youthful gene expression in targeted cells, specifically focusing on brain diseases like Alzheimer's. By rejuvenating neuronal and glial cells, the company aims to improve cognitive function and delay age-related cognitive decline.

```xml <problem> Age-related brain diseases, such as Alzheimer's, lead to cognitive decline due to the degradation of neuronal and glial cells. Current treatments offer limited efficacy in restoring youthful gene expression and improving overall cognitive function in affected individuals. </problem> <solution> YouthBio Therapeutics develops tissue-specific gene therapies leveraging partial cellular reprogramming to rejuvenate cells and restore a more youthful gene expression profile. The company focuses on targeting key organ systems, starting with single-organ therapies aimed at brain diseases like Alzheimer's. By reprogramming neuronal and glial cells, YouthBio aims to improve cognitive function and potentially delay or reverse age-related cognitive decline. Their approach seeks to address the underlying causes of aging at the cellular level, offering a potential path towards systemic rejuvenation. </solution> <features> - Tissue-specific gene therapies targeting neuronal and glial cells - Partial cellular reprogramming to restore youthful gene expression - Focus on brain diseases such as Alzheimer's - Aims to improve cognitive function and delay age-related cognitive decline </features> <target_audience> The primary target audience includes individuals affected by age-related cognitive decline and brain diseases like Alzheimer's, as well as healthcare providers and researchers in the field of regenerative medicine. </target_audience> ```

What does YouthBio Therapeutics do?

Where is YouthBio Therapeutics located?

YouthBio Therapeutics is based in Seattle, United States.

When was YouthBio Therapeutics founded?

YouthBio Therapeutics was founded in 2020.

Location

Seattle, United States

Founded

2020

Employees

3 employees

Major Investors

MassChallenge

Find Investable Startups and Competitors

Search thousands of startups using natural language

AI voice (2021+)underground pipe robots energy flexibility software

Start Searching

YouthBio Therapeutics

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

youthbiotx.com 500+

Crunchbase

Founded 2020 – Seattle, United States

Funding

Major Investors

MassChallenge

Team (<5)

No team information available.

Company Description

Problem

Age-related brain diseases, such as Alzheimer's, lead to cognitive decline due to the degradation of neuronal and glial cells. Current treatments offer limited efficacy in restoring youthful gene expression and improving overall cognitive function in affected individuals.

Solution

YouthBio Therapeutics develops tissue-specific gene therapies leveraging partial cellular reprogramming to rejuvenate cells and restore a more youthful gene expression profile. The company focuses on targeting key organ systems, starting with single-organ therapies aimed at brain diseases like Alzheimer's. By reprogramming neuronal and glial cells, YouthBio aims to improve cognitive function and potentially delay or reverse age-related cognitive decline. Their approach seeks to address the underlying causes of aging at the cellular level, offering a potential path towards systemic rejuvenation.

Features

Tissue-specific gene therapies targeting neuronal and glial cells

Partial cellular reprogramming to restore youthful gene expression

Focus on brain diseases such as Alzheimer's

Aims to improve cognitive function and delay age-related cognitive decline

Target Audience

The primary target audience includes individuals affected by age-related cognitive decline and brain diseases like Alzheimer's, as well as healthcare providers and researchers in the field of regenerative medicine.